April 30, 2026
Background On March 31, a divided 2-1 panel of the U.S Court of Appeals for the Fourth Circuit decided that the federal drug discount provisions under Section 340B of the Public Health [...]
April 8, 2026
On March 31, 2026, the U.S. Court of Appeals for the Fourth Circuit, in a 2-1 decision, upheld a preliminary injunction blocking enforcement of West Virginia’s 340B contract pharmacy law. The statute [...]
March 27, 2026
Feldesman Partner Steve Kuperberg was recently quoted in the 340B Report in connection with a U.S. Senate investigation into drug pricing practices and their broader impact on safety-net providers. The article examines a [...]
February 27, 2026
Feldesman Partner Steve Kuperberg was recently quoted in the February 26, 2026, edition of the 340B Report on the federal government’s decision to support drug manufacturers in litigation challenging state 340B contract [...]
January 2, 2026
The U.S. District Court for the District of Maine has issued a temporary restraining order blocking the Health Resources and Services Administration’s (HRSA) 340B Rebate Model Pilot Program from taking effect on [...]
September 15, 2025
On Friday, September 12, 2025, the U.S. Court of Appeals for the Fifth Circuit issued an unpublished decision upholding a Mississippi law that protects 340B contract pharmacy arrangements. The ruling came in [...]

